WEISLER DION J 4

What Happened

• Dion J. Weisler, a director of Thermo Fisher Scientific (TMO), was granted 73.1 deferred stock units (reported as a derivative award "A") on June 27, 2026.
• The units were credited at $513.03 per unit, valuing the award at approximately $37,502 (73.1 × $513.03). This was an award/compensation credit—not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-27; Form 4 filed: 2026-06-30. The filing shows the grant date and the filing date; verify SEC records if you need timeliness confirmation.
• Price per unit: $513.03; units granted: 73.1; approximate value: $37,502.
• Shares owned after transaction: not disclosed on the Form 4 provided.
• Footnotes: F1 — each unit is convertible into one common share on a 1-for-1 basis. F2 — these are stock units credited under the Issuer’s Deferred Compensation Plan for Directors; retainers are deferred quarterly as stock units and are distributable as stock upon cessation of director service or a change of control.

Context

• This is routine director compensation (an award under the deferred-comp plan), which is common and does not by itself indicate the director is buying or selling shares for investment reasons. The units are derivatives representing future common shares and will convert or be distributed per the plan terms.